2018
DOI: 10.1016/j.phrs.2018.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Targeting neurotrophin signaling in cancer: The renaissance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
52
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 78 publications
(59 citation statements)
references
References 70 publications
4
52
0
3
Order By: Relevance
“…More and more studies support the importance of nerve-derived signals in organ development, homeostasis, regeneration, and in pathological conditions [20,68]. It is well known that most cancers are associated with pain sensation [69], and different studies have reported the expression of neurotrophic factors in many cancer types [70][71][72][73][74]. Only recently a few studies have started shedding light on the fundamental role of innervation for cancer onset and progression.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…More and more studies support the importance of nerve-derived signals in organ development, homeostasis, regeneration, and in pathological conditions [20,68]. It is well known that most cancers are associated with pain sensation [69], and different studies have reported the expression of neurotrophic factors in many cancer types [70][71][72][73][74]. Only recently a few studies have started shedding light on the fundamental role of innervation for cancer onset and progression.…”
Section: Discussionmentioning
confidence: 97%
“…Their expression thus leads to neuroattraction and, at the same time, could induce activation of neurotrophin signaling within cancer cells themselves. Neurotrophins and their receptors are attracting increasing attention as therapeutic targets in many cancer types, as pharmacological interventions against this signaling axis have the potential to not only target cancer cells directly, but also to inhibit neurogenesis and its stimulatory effects on cancer progression and pain [73,84]. Indeed neural regulation represents an emerging targetable pathway for the treatment of cancer [75,76,78,85].…”
Section: Discussionmentioning
confidence: 99%
“…Animal experiments and clinical trials have already shown that systemic injections of anti-NGF antibodies have no significant impact on neuronal and cognitive activities (75). NGF has a neurotrophic effect that drives tumor axonogenesis (10,28,30); thus, targeting NGF could prevent the outgrowth of nerves in the tumor microenvironment (76). The use of anti-NGF blocking antibodies and inhibitors for TrkA (77) or NGF-targeting siRNA encapsulated into nanoparticles (78) has already demonstrated the ability to decrease cancer growth and metastasis in animal models, with further translation into clinical trials warranted.…”
Section: Targeting Neurotrophic Factorsmentioning
confidence: 99%
“…The exact linkage between neoneurogenesis and tumorigenesis of TSCC has not been uncovered, the underlying mechanisms may involve: ① Newly formed nerves can secret high level of neurotrophin family factors, such as nerve growth factor (NGF), which is contributed to the survival and proliferation of cancer cells [21,22]; ② Malignant tumors depend on angiogenesis to fuels its ability to grow and spread, endothelial β-adrenergic receptor signaling via adrenergic nerve-derived noradrenaline is critical for activation of an angiogenic switch to promote tumor angiogenesis which can facilitate rapid tumor growth [23][24][25]; ③ β2-adrenergic receptor (β2-AR) has been reported to be a potential promoter to cancer initiation and aggressiveness in various types of solid cancer [26]. Liu discovered that increased expression of β2-AR was correlated with differentiation, lymph node metastasis and reduced overall survival rate in patients with TSCC [27].…”
Section: Discussionmentioning
confidence: 99%